Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
出版年份 2020 全文链接
标题
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-05-05
DOI
10.3389/fimmu.2020.00613
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria
- (2019) Raffi Topakian et al. JOURNAL OF NEUROLOGY
- Rituximab in myasthenia gravis: a “to be or not to be” inhibitor of T cell function
- (2018) Mariapaola Marino et al. Annals of the New York Academy of Sciences
- IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders
- (2018) Maartje G. Huijbers et al. Annals of the New York Academy of Sciences
- Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis
- (2018) Panos Stathopoulos et al. Annals of the New York Academy of Sciences
- On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease
- (2018) David C. Trampert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Rituximab in refractory myasthenia gravis: extended prospective study results
- (2018) Grayson Beecher et al. MUSCLE & NERVE
- Targeting B Cells and Plasma Cells in Autoimmune Diseases
- (2018) Katharina Hofmann et al. Frontiers in Immunology
- The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis
- (2018) Elena Cortés-Vicente et al. Annals of Clinical and Translational Neurology
- IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
- (2017) Inga Koneczny et al. JOURNAL OF AUTOIMMUNITY
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- B cells in the pathophysiology of myasthenia gravis
- (2017) John S. Yi et al. MUSCLE & NERVE
- Rituximab as treatment for anti-MuSK myasthenia gravis
- (2017) Michael K. Hehir et al. NEUROLOGY
- Durability of the Rituximab Response in Acetylcholine Receptor Autoantibody–Positive Myasthenia Gravis
- (2017) Kimberly R. Robeson et al. JAMA Neurology
- Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients
- (2017) Mikael Ebbo et al. PLoS One
- International consensus guidance for management of myasthenia gravis
- (2016) Donald B. Sanders et al. NEUROLOGY
- Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up
- (2016) Dustin Anderson et al. Annals of Clinical and Translational Neurology
- The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
- (2014) Helena Marco et al. BMC MUSCULOSKELETAL DISORDERS
- Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis
- (2014) Raffaele Iorio et al. JOURNAL OF NEUROLOGY
- What Is and What Should Always Have Been: Long-Lived Plasma Cells Induced by T Cell-Independent Antigens
- (2013) A. Bortnick et al. JOURNAL OF IMMUNOLOGY
- Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1
- (2013) Benison Keung et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
- (2013) M. G. Huijbers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Management challenges in muscle-specific tyrosine kinase myasthenia gravis
- (2012) Amelia Evoli et al. Annals of the New York Academy of Sciences
- Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
- (2012) Rinse Klooster et al. BRAIN
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab for the Treatment of IgG4-Related Disease
- (2011) Arezou Khosroshahi et al. MEDICINE
- Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
- (2011) Richard J. Nowak et al. Therapeutic Advances in Neurological Disorders
- Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
- (2010) Arezou Khosroshahi et al. ARTHRITIS AND RHEUMATISM
- Immunosuppressive therapies in myasthenia gravis
- (2010) Donald B. Sanders et al. AUTOIMMUNITY
- Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece
- (2009) P. Tsiamalos et al. EUROPEAN JOURNAL OF NEUROLOGY
- Rebooting the Immune System with High-Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis
- (2008) Daniel B. Drachman et al. Annals of the New York Academy of Sciences
- Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1
- (2008) E.H. Niks et al. JOURNAL OF NEUROIMMUNOLOGY
- B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders
- (2008) J STUBGEN JOURNAL OF NEUROIMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started